Chronic Disease Prevention : Glutathione helps mitigate the effects of chronic conditions like Parkinsons disease, Alzheimers, and nonalcoholic fatty liver disease by reducing oxidative damage and inflammation
7 Although metabolic changes were present, the rapid dermatologic response raised the possibility of additional mechanisms, such as direct modulation of cutaneous immune pathways
The 2022 ASMBS/IFSO guidelines recommend consideration for patients with BMI 35 kg/m regardless of comorbidities, and for those with BMI 30-34.9 kg/m with metabolic disease
[4] Practical guidance for patients and healthcare professionals: GLP-1 receptor agonists should be prescribed according to their licensed indications (type 2 diabetes and, for specific agents, weight management) Patients with diabetes and cognitive concerns should ensure optimal management of all cardiovascular risk factors, including blood pressure, cholesterol, and glycaemic control Lifestyle interventionsincluding regular physical activity, Mediterranean-style diet, cognitive engagement, and social interactionremain the most evidence-based approaches to reducing dementia risk Anyone experiencing memory problems, confusion, or cognitive changes should contact their GP for proper assessment and potential referral to a memory clinic Seek urgent medical attention for sudden confusion, rapidly worsening symptoms, stroke-like symptoms, or cognitive changes following head injury Patients should not discontinue or commence GLP-1 receptor agonists based solely on potential cognitive effects without medical consultation The field of GLP-1 research in neurodegeneration represents an exciting area of investigation, but clinical recommendations must await robust trial evidence demonstrating clear benefit and acceptable safety profiles in relevant populations
Mowat AM: Anatomical basis of tolerance and immunity to intestinal antigens
Websites like Honest Peptide and BioLongevity Labs sell BPC-157 lyophilized powder in 5 or 10 mg vials
